BiotechTube
Home/Protomer Technologies/Ryan Spencer, PhD
RS

Ryan Spencer, PhD

Chemistry

Protomer Technologies

Therapeutic Areas

Metabolic Disease

Protomer Technologies Pipeline

DrugIndicationPhase
Glucose-Responsive Insulin Receptor AgonistDiabetesPre-clinical (integrated into Lilly pipeline)

Leadership Team at Protomer Technologies

AM
Alborz Mahdavi, PhD
CEO
JS
Jack Steele
COO
DC
Diao Chen, PhD
Chemistry
SM
Sachin Mali, PhD
Chemistry
View full Protomer Technologies profile